David Chen

Principal Diagnostics Development Leader
Genentech Inc.
San Francisco, California, United States

Presentation(s):

• PB0252 - NXT007, a novel bispecific antibody, in FVIII chromogenic substrate assays

  Sunday, June 23, 2024
  13:45 – 14:45 ICT